{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:22:20Z","timestamp":1790634140563,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.taap.2021.115680","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T23:45:43Z","timestamp":1629157543000},"page":"115680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Evaluation of chronic toxicity of cyclocreatine in beagle dogs after oral gavage administration for up to 23\u00a0weeks"],"prefix":"10.1016","volume":"430","author":[{"given":"Jeffrey J.","family":"Wallery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay Pralhad","family":"Kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh-Ha T.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"McKew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod S.","family":"Terse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2021.115680_bb0005","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/syn.20280","article-title":"Exocytotic release of creatine in rat brain","volume":"60","author":"Almeida","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.taap.2021.115680_bb0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1471-4159.2010.06935.x","article-title":"Synthesis and transport of creatine in the CNS: importance for cerebral functions","volume":"115","author":"Beard","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2021.115680_bb0015","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1177\/0192623312474865","article-title":"STP position paper: recommended practices for sampling and processing the nervous system (brain, spinal cord, nerve, and eye) during nonclinical general toxicity studies","volume":"41","author":"Bolon","year":"2013","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2021.115680_bb0020","doi-asserted-by":"crossref","first-page":"18361","DOI":"10.1038\/s41598-020-75436-4","article-title":"Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine transporter deficiency","volume":"10","author":"Cacciante","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2021.115680_bb0025","doi-asserted-by":"crossref","first-page":"104939","DOI":"10.1016\/j.yrtph.2021.104939","article-title":"Use of an animal model of disease for toxicology enables identification of a juvenile no observed adverse effect level for cyclocreatine in creatine transporter deficiency","volume":"123","author":"Do","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2021.115680_bb0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-201x.2001.00786.x","article-title":"Effect of creatine supplementation on creatine and glycogen content in rat skeletal muscle","volume":"171","author":"Eijnde","year":"2001","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.taap.2021.115680_bb0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1006895414925","article-title":"Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo: down-regulation of the expression of creatine transporter isoforms in skeletal muscle","volume":"184","author":"Guerrero-Ontiveros","year":"1998","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.taap.2021.115680_bb0040","doi-asserted-by":"crossref","first-page":"104483","DOI":"10.1016\/j.yrtph.2019.104483","article-title":"Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis","volume":"109","author":"Kale","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2021.115680_bb0045","doi-asserted-by":"crossref","first-page":"104750","DOI":"10.1016\/j.yrtph.2020.104750","article-title":"Evaluation of chronic toxicity of cyclocreatine, a creatine analog, in Sprague Dawley rat after oral gavage administration for up to 26 weeks","volume":"117","author":"Kale","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2021.115680_bb0050","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1172\/JCI59373","article-title":"Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency","volume":"122","author":"Kurosawa","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2021.115680_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/CS20030116","article-title":"Creatine supplementation increases glycogen storage but not GLUT-4 expression in human skeletal muscle","volume":"106","author":"van Loon","year":"2004","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.taap.2021.115680_bb0060","doi-asserted-by":"crossref","first-page":"2691S","DOI":"10.1093\/jn\/128.12.2691S","article-title":"Changes in plasma and muscle creatine concentration after increases in supplementary dietary creatine in dogs","volume":"128","author":"Lowe","year":"1998","journal-title":"J. Nutr."},{"key":"10.1016\/j.taap.2021.115680_bb0065","doi-asserted-by":"crossref","first-page":"12034","DOI":"10.1016\/S0021-9258(20)71316-5","article-title":"Repression of rat kidney L-arginine:glycine amidinotransferase synthesis by creatine at a pretranslational level","volume":"259","author":"McGuire","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2021.115680_bb0070","series-title":"Simultaneous Statistical Inference","author":"Miller","year":"1981"},{"key":"10.1016\/j.taap.2021.115680_bb0075","series-title":"X-Linked Creatine Deficiency","author":"NLM","year":"2019"},{"key":"10.1016\/j.taap.2021.115680_bb0080","series-title":"Guide for the Care and Use of Laboratory Animals","author":"NRC","year":"2011"},{"key":"10.1016\/j.taap.2021.115680_bb0085","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.WCB.0000033966.83623.7D","article-title":"The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain","volume":"22","author":"Ohtsuki","year":"2002","journal-title":"J. Cerebr. Blood F. Met."},{"key":"10.1016\/j.taap.2021.115680_bb0090","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00726-016-2252-x","article-title":"Creatine ingestion augments dietary carbohydrate mediated muscle glycogen supercompensation during the initial 24 h of recovery following prolonged exhaustive exercise in humans","volume":"48","author":"Roberts","year":"2016","journal-title":"Amino Acids"},{"key":"10.1016\/j.taap.2021.115680_bb0095","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/320595","article-title":"X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome","volume":"68","author":"Salomons","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.taap.2021.115680_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/1550-2783-3-1-60","article-title":"The regulation and expression of the Creatine transporter: a brief review of Creatine supplementation in humans and animals","volume":"3","author":"Schoch","year":"2006","journal-title":"J. Int. Soc. Sport Nutr."},{"key":"10.1016\/j.taap.2021.115680_bb0105","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/B978-0-444-59565-2.00053-8","article-title":"Creatine deficiency syndromes","volume":"113","author":"Schulze","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.taap.2021.115680_bb0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1011908606819","article-title":"Creatine and the creatine transporter: a review","volume":"224","author":"Snow","year":"2001","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.taap.2021.115680_bb0115","doi-asserted-by":"crossref","first-page":"875","DOI":"10.18388\/abp.2004_3520","article-title":"Biochemical and clinical characteristics of creatine deficiency syndromes","volume":"51","author":"Sykut-Cegielska","year":"2004","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.taap.2021.115680_bb0120","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1471-4159.1980.tb09966.x","article-title":"Utilization of cyclocreatine phosphate, and analogue of creatine phosphate, by mouse brain during ischemia and its sparing action on brain energy reserves","volume":"34","author":"Woznicki","year":"1980","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2021.115680_bb0125","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol. Rev."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21002842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21002842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:55:20Z","timestamp":1758574520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X21002842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":25,"alternative-id":["S0041008X21002842"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2021.115680","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of chronic toxicity of cyclocreatine in beagle dogs after oral gavage administration for up to 23\u00a0weeks","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2021.115680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115680"}}